HBOT.COM

Giving people back their lives!

Good News on Veteran's Day 2012: Treatment for PTSD and TBI Among Veterans Shows Results

Good News on Veteran's Day 2012: Treatment for PTSD and TBI Among Veterans of Iraq and Afghanistan Shows Results

Paul G. Harch, M.D. announces successful treatment of PTSD (Post Traumatic Stress Disorder) and TBI (Traumatic Brain Injury) for veterans suffering from debilitating concussive brain injury.

(New Orleans, LA) November 05, 2012 -- Following publication of the first case of HBOT (Hyperbaric Oxygen Therapy) benefiting veterans with TBI and PTSD in 2009, Dr. Harch and colleagues published confirmatory evidence in January of this year in the prestigious peer-reviewed Journal of Neurotrauma. http://www.liebertonline.com/doi/abs/10.1089/neu.2011.1895

In September 2012, Dr. Harch's research team showed that the HBOT treatments generated improvements in depression and anxiety, PTSD, and memory that resulted in quality-of-life improvements for veterans. The study further indicated, statistically, that a "chance explanation" for the improvements in the veterans was less than "one in a quadrillion". http://online.liebertpub.com/doi/abs/10.1089/neu.2012.2608

"We announce this Veteran's Day, that we have a promising treatment, utilizing scientific methods of precise dosage and protocol, that may permanently curtail TBI and PTSD symptoms, returning veterans to a more normalized life," states Dr. Harch.

As a result of their experiences in both wars, soldiers often suffer from unbearable headaches, dizziness, depression, nightmares, and violent mood swings. Dr. Harch, a leading expert in emergency medicine and hyperbaric treatment has pioneered brain injury research for over two decades. His credentials, studies, and reputation are known worldwide. For more on Dr. Harch, visit www.HBOT.com.

The Department of Defense (DoD), the Veteran's Administration (VA), and the National Institute of Mental Health (NIMH) recently pledged $100 million for further PTSD and TBI studies and treatment research, impacting over 550,000 brain injured veterans.

Among veterans of the wars in Iraq and Afghanistan, traumatic brain injury is the leading cause of disability, labeled, "The signature wound of the war on terror".

Chad Battles, an Army E4 machine gunner specialist, says of his recent HBOT treatment with Dr. Harch, "I didn't know what to do. The VA tried, but couldn't relieve me of my sleepless nights, my recurring nightmares, loss of memory, and chronic headaches. I found Dr. Harch and he treated me pro bono. After 40 'dives', my memory came back, my headaches were gone, and I am able to sleep through the night. He basically gave me my life back!"

HBOT was first used by the U.S. Navy in treatment of divers experiencing "the bends". Since that application, the FDA has approved no less than 14 different "indications" using HBOT. Other countries realize HBOT benefits in excess of 75 different "indications".

Here's how HBOT works: Increased air pressure forces oxygen into the fluids and tissues of the body, significantly augmenting the usual oxygen delivery system through the blood. This oxygen infusion can reach inaccessible, dormant cells, restoring their normal function. In addition, research has shown that HBOT increases the amount of stem cells released from one's bone marrow, healing the injury with new, healthy cells. For more on Dr. Harch and Harch Hyperbaric Oxygen, visit www.HBOT.com or call toll free, 1-855-GET-HBOT.

Paul G. Harch, M.D. is the foremost leader in hyperbaric medicine. Dr. Harch leads the nation with his treatment of military veterans suffering with PTSD (Post Traumatic Stress Disorder) and TBI (Traumatic Brain Injury). Dr. Harch is world renown for his clinical research, dedication, and his specific protocols in treatment with oxygen. His bestselling book, "The Oxygen Revolution", published by Hatherleigh Press, demonstrates the remarkable and often overlooked life and quality-of-life healing potential provided by using oxygen as a drug. A drug to heal a variety of acute and chronic conditions. HIs testimony before the U.S. Congress has led to significant advances in hyperbaric medicine treatment.